Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.
Seremet T, Jansen Y, Planken S, Njimi H, Delaunoy M, El Housni H, Awada G, Schwarze JK, Keyaerts M, Everaert H, Lienard D, Del Marmol V, Heimann P, Neyns B. Seremet T, et al. Among authors: schwarze jk. J Transl Med. 2019 Sep 5;17(1):303. doi: 10.1186/s12967-019-2051-8. J Transl Med. 2019. PMID: 31488153 Free PMC article.
Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
Rogiers A, Leys C, Lauwyck J, Schembri A, Awada G, Schwarze JK, De Cremer J, Theuns P, Maruff P, De Ridder M, Bernheim JL, Neyns B. Rogiers A, et al. Among authors: schwarze jk. J Immunol Res. 2020 Jul 21;2020:2192480. doi: 10.1155/2020/2192480. eCollection 2020. J Immunol Res. 2020. PMID: 32775464 Free PMC article. Clinical Trial.
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx).
Awada G, Ben Salama L, De Cremer J, Schwarze JK, Fischbuch L, Seynaeve L, Du Four S, Vanbinst AM, Michotte A, Everaert H, Rogiers A, Theuns P, Duerinck J, Neyns B. Awada G, et al. Among authors: schwarze jk. J Immunother Cancer. 2020 Oct;8(2):e001146. doi: 10.1136/jitc-2020-001146. J Immunother Cancer. 2020. PMID: 33067319 Free PMC article. Clinical Trial.
Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial.
Schwarze JK, Awada G, Cras L, Tijtgat J, Forsyth R, Dufait I, Tuyaerts S, Van Riet I, Neyns B. Schwarze JK, et al. Vaccines (Basel). 2020 Nov 10;8(4):670. doi: 10.3390/vaccines8040670. Vaccines (Basel). 2020. PMID: 33182610 Free PMC article.
35 results